This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Randolph Escobar
Introduction
Randolph Escobar is an inventor based in Gaithersburg, MD (US). He is known for his contributions to the field of cancer treatment through innovative chemical compounds. His work focuses on developing inhibitors that target specific kinases involved in cancer progression.
Latest Patent Applications
Randolph Escobar has submitted a patent application titled "SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER." This application discloses certain substituted pyrazine-2-carboxamides of Formula (I), along with their pharmaceutically acceptable salts. The compounds are designed to inhibit hematopoietic progenitor kinase 1 (HPK1), making them particularly useful in the treatment or prophylaxis of cancer.
Conclusion
Randolph Escobar's innovative work in developing HPK1 inhibitors represents a significant step forward in cancer therapy. His ongoing research and patent applications highlight the potential for new treatments in the fight against cancer.